Please use this identifier to cite or link to this item:
http://hdl.handle.net/11434/2137| Title: | Evaluation of antidepressant use in pregnancy and Apgar Score at birth: a retrospective single centre Australian study. |
| Epworth Authors: | Chong, Ee Lyn Lee, Sze Way McKenzie, Dean |
| Keywords: | Antidepressant Use Pregnancy Selective Serotonin Reuptake Inhibitor SSRI Apgar Score Newborn Status Epworth Research Women’s and Children’s Clinical Institute, Epworth HealthCare, Victoria, Australia |
| Issue Date: | Oct-2022 |
| Conference Name: | Epworth HealthCare Research Month 2022 |
| Conference Location: | Epworth Research Institute, Victoria, Australia |
| Abstract: | Approximately 15-20% of pregnant women experienced anxiety and/or depression in Australia. Many studies have suggested that selective serotonin reuptake inhibitor (SSRI) is associated with low Apgar score at birth. Apgar score is a standardized way of examining a newborn status and a score of less than seven at 5 minutes could lead to multiple developmental issues in later life. Therefore, it is understandable that pregnant women remain fearful of continuing their antidepressants. Our aim is to investigate the association between maternal use of SSRI and Apgar score of newborns at 1 minute and 5 minutes of life in an Australian cohort. |
| URI: | http://hdl.handle.net/11434/2137 |
| Type: | Conference Poster |
| Type of Clinical Study or Trial: | Retrospective cohort studies |
| Appears in Collections: | Research Week |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Chong, E Evaluation of Antidepressant Use in Pregnancy and Apgar Score at Birth.pdf | 283.3 kB | Adobe PDF |  View/Open |
Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.